NASDAQ:PDSB

Pds Biotechnology Stock Forecast

etoro logo Buy PDSB
*Your capital is at risk
$1.02
-0.200 (-16.39%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of PDSB AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add PDSB to Watchlist?
  • Easy Tracking In The Watchlist
PDF

High volatility in PDS Biotechnology Corp. stock price on Friday which ended trading at $1.02
(Updated on Jun 05, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Jun 04, 2026 Loss -16.39%

The PDS Biotechnology Corp. stock price fell by -16.39% on the last day (Friday, 5th Jun 2026) from $1.22 to $1.02. During the last trading day the stock fluctuated 23.75% from a day low at $1.01 to a day high of $1.25. The price has risen in 6 of the last 10 days but is still down by -12.07% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 million shares and in total, 0 shares were bought and sold for approximately $0 .

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.94 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 60.52% during the next 3 months and, with a 90% probability hold a price between $1.51 and $2.78 at the end of this 3-month period.

PDSB Signals & Forecast

There are few to no technical positive signals at the moment. The PDS Biotechnology Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.11 and $1.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -16.39%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for PDS Biotechnology Corp. stock

PDS Biotechnology Corp. finds support from accumulated volume at $1.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0.240 between high and low, or 23.75%. For the last week the stock has had daily average volatility of 14.19%

Our recommended stop-loss: $0.96 (-6.26%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (PDSB) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect PDS Biotechnology Corp. to open at $1.09, and during the day (based on 14 day Average True Range), to move between $0.95 and $1.09, which gives a possible trading interval of +/-$0.148 (+/-15.68%) up or down from last closing price. If PDS Biotechnology Corp. takes out the full calculated possible swing range there will be an estimated 15.68% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.00 (1.96%) than the resistance at $1.07 (4.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is PDS Biotechnology Corp. stock A Buy?

PDS Biotechnology Corp. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: -0.948 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.09 ( 7.19%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

PDSB Performance

Trading levels for PDSB

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.33 30.71%
R2 1.24 21.72%
R1 1.18 16.17%
Price 1.02
S1 1.00 -1.80%
S2 0.95 -7.35%
S3 0.85 -16.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.10 7.84%
R2 1.08 5.88%
R1 1.07 4.90%
Price 1.02
S1 1.00 -1.96%
S2 0.93 -9.01%
S3 0.92 -10.00%

FAQ

What is the symbol for PDS Biotechnology Corp. Stock and on which exchange is it traded?
The symbol for PDS Biotechnology Corp. is PDSB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PDS Biotechnology Corp. Stock?
PDS Biotechnology Corp. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy PDS Biotechnology Corp. Stock?
PDS Biotechnology Corp. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PDS Biotechnology Corp. Stock.

What's the current price of PDS Biotechnology Corp. Stock?
As of the end of day on the Jun 05, 2026, the price of an PDS Biotechnology Corp. (PDSB) share was $1.02.

What is the 52-week high and low for PDS Biotechnology Corp. Stock?
The 52-week high for PDS Biotechnology Corp. Stock is $1.92 and the 52-week low is $0.520.

What is the market capitalization of PDS Biotechnology Corp. Stock?
As of the Jun 05, 2026, the market capitalization of PDS Biotechnology Corp. is 56.932M.

When is the next earnings date for PDS Biotechnology Corp.?
The upcoming earnings date for PDS Biotechnology Corp. is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT PDS BIOTECHNOLOGY CORP.
PDS Biotechnology
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclini...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE